Research and Development

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …

Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer.  “Eric has tremendous experience and …

The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …

Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …

Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer.  Bob Radie, president and chief …

Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer.  Starting in …

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …